Experience

Davis Polk is advising the special committee of the board of directors of Ormat Technologies, Inc. in connection with the acquisition of an approximately $627 million ownership stake…

On March 16, 2017 a New York appellate court in Manhattan affirmed a ruling dismissing claims against Davis Polk’s client, Castleton Commodities International LLC. The claims concerned call…

On March 15, 2017, the Appellate Division of the Supreme Court of the State of New York, First Judicial Department affirmed summary judgment for Morgan Stanley in a case commenced by IDT…

Davis Polk is advising the Special Committee of Independent Directors of Fortress Investment Group LLC in connection with the approximately $3.3 billion acquisition of Fortress by SoftBank…

Davis Polk advised the special committee of the board of directors of OneMain Holdings, Inc. in connection with the sale of its 47% interest in SpringCastle, a joint venture formed to…

We successfully resolved several disputes on behalf of the wind energy company

Davis Polk is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by OPKO Health, Inc. Under the terms of the agreement, holders of Bio…

Davis Polk successfully represented Dialog Semiconductors in litigation related to the earnout provisions in its 2013 acquisition of iWatt. In April 2014, Fortis Advisors—acting on behalf…

Davis Polk is advising Micrel, Incorporated in connection with its sale to Microchip Technology Incorporated for a total equity value of approximately $839 million. The transaction,…

Davis Polk is advising Mavenir Systems, Inc. in connection with the acquisition of all of its outstanding shares of common stock by Mitel Networks Corporation in a cash and stock deal…